Silicon Valley venture fund Fin VC led the investment, with additional backing from Barclays Bank.
"We have been growing steadily over the past few years, ramping up our technology and team to better understand businesses, the nature of B2B debt and to make faster decisions to serve our growing customer base. 2020 was a seminal year for Nimbla, at a time of global crisis, we were there for businesses enabling them to trade with a peace of mind and giving them confidence to carry on. This funding round will enable us to expand our platform, grow the team as we enable a confident and trusted trading environment for businesses across the UK and beyond"
The seed round was co-led by PROfounders and Revent with participation from Northzone and Nomad Capital.
"Breakroom’s mission is to make every job a good job. Most people don’t work from offices: they’re on the frontline, working shifts and many of them are paid by the hour. The pandemic has shown that there are too many jobs that are undervalued and need to improve. The recent labour shortages in sectors like logistics and hospitality show that now is a great time to make sure that things are different in the future. Breakroom will help workers find the best job for them and help employers compete on the quality of the jobs they offer."
The round was backed by Chasnay Capital Partners alongside existing investors, retail investors, and Innovate UK.
"My north star is who I work with, and the level of enthusiasm, passion and desire to do great things at SleepCogni is outstanding. SleepCogni is a great example of hardware and software working together to have a truly life changing impact on patients."
The seed round was backed by QVentures and various angel investors.
"Empowering product managers, designers and engineers to build the right thing is important. It reduces waste and results in happier customers. It is a problem we are familiar with first and are obsessed with solving."
The Series A round was led by Maven VC and Guinness Asset Management to support post-pandemic healthcare recovery.
"As we continue to accelerate and invest in the ethical use of clinical research data to advance new medicines for patient care, this funding gives us the capital needed to carry out our immediate plans while delivering AI solutions which will help futureproof our NHS."
